Given that AML patients with monocytic differentiation and del7/7q are reported to have resistance to venetoclax-based therapy10,53, we evaluated the correlation of IFNγ signaling score with drug sensitivity. The gene discussed is IFNG; the disease is acute myeloid leukemia.